Literature DB >> 3081434

Control of immunoglobulin class switch recombination.

A Radbruch, C Burger, S Klein, W Müller.   

Abstract

The comparative analysis of Ig class switch recombination in a priori IgG/IgA-expressing myelomas and hybridomas, in switch variants and in activated normal B cells shows the following characteristics of class switch recombination in activated B cells: It is prevented during most of B cell ontogeny. It happens on both IgH loci of activated and switched B cells. The recombination is programmed in that on both IgH loci of switched cells the same switch regions recombine with Smu. This is true at least for the IgG1 pathway. IgM-expressing cells show no class switch recombination on the inactive IgH locus. Thus, physiological class switch recombination is a programmed rather than a random event and is controlled as such. The initial stages of class switching and the molecules involved in these are largely unclear: What is the nature of the protection of switch regions and how is this protection abrogated? Do specific recombinases exist? What is the role of large transcription units? Is the specificity of class switch recombination a result of specific "opening" of the DNA for transcription? Do all B cells use the same switch mechanism? What is the role of switch factors (such as lymphokines)? These and more questions await answers and although a variety of switch scenarios could be discussed at present a detailed speculation seems premature.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081434     DOI: 10.1111/j.1600-065x.1986.tb01473.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  19 in total

Review 1.  The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.

Authors:  J F Knight
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

Review 2.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Cognate T-cell help in the induction of IgA responses in vivo.

Authors:  M L Dunkley; A J Husband; B J Underdown
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

Review 4.  Regulation of IgA synthesis and immune response by T cells and interleukins.

Authors:  J R McGhee; J Mestecky; C O Elson; H Kiyono
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

5.  An in vitro model of allergen-dependent IgE synthesis by human B lymphocytes: comparison of the response of an atopic and a non-atopic individual to Dermatophagoides spp. (house dust mite).

Authors:  R E O'Hehir; V Bal; D Quint; R Moqbel; A B Kay; E D Zanders; J R Lamb
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

6.  Structure and expression of germ line immunoglobulin gamma 2b transcripts.

Authors:  S Lutzker; F W Alt
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

7.  The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region.

Authors:  P Matthias; D Baltimore
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

8.  Clonal variants of hybridoma cells that switch isotype at a high frequency.

Authors:  G Spira; P Gregor; H L Aguila; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Transcription of productive and nonproductive VDJ-recombined alleles after IgH allelic exclusion.

Authors:  Janssen Daly; Steve Licence; Aikaterini Nanou; Geoff Morgan; Inga-Lill Mårtensson
Journal:  EMBO J       Date:  2007-09-06       Impact factor: 11.598

10.  Anomalous rearrangements of the immunoglobulin heavy chain genes in human leukemias support the loop-out mechanism of class switch.

Authors:  M Laffan; L Luzzatto
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.